COVID-19 in Elderly, Immunocompromised or Diabetic Patients—From Immune Monitoring to Clinical Management in the Hospital
The novel, highly transmissible severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has triggered a pandemic of acute respiratory illness worldwide and remains a huge threat to the healthcare system’s capacity to respond to COVID-19. Elderly and immunocompromised patients are at increased r...
Main Authors: | Korbinian Wünsch, Olympia E. Anastasiou, Mira Alt, Leonie Brochhagen, Maxim Cherneha, Laura Thümmler, Lukas van Baal, Rabea J. Madel, Monika Lindemann, Christian Taube, Oliver Witzke, Hana Rohn, Adalbert Krawczyk, Sarah Jansen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/14/4/746 |
Similar Items
-
Long-term cellular immune response in immunocompromised unvaccinated COVID-19 patients undergoing monoclonal antibody treatment
by: Laura Thümmler, et al.
Published: (2022-10-01) -
The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts
by: Caroline Holtkamp, et al.
Published: (2022-01-01) -
Rhino-Orbito-Cerebral Mucormycosis in an Immunocompromised Patient
by: Heung Eog Cha, et al.
Published: (2022-07-01) -
Fatal sepsis by Bacillus circulans in an immunocompromised patient
by: M Alebouyeh, et al.
Published: (2011-09-01) -
Pulmonary tuberculosis in the immunocompromised patients
by: Vukosav Danijela, et al.
Published: (2019-01-01)